Trials / Conditions / Eosinophilic Duodenitis
Eosinophilic Duodenitis
5 registered clinical trials studyying Eosinophilic Duodenitis.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | A Study to Assess Subcutaneous AK002 in Eosinophilic Gastritis and/or Eosinophilic Duodenitis NCT05152563 | Allakos Inc. | Phase 3 |
| Completed | A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Duodenitis NCT04856891 | Allakos Inc. | Phase 3 |
| Completed | An Extension Study of Lirentelimab in Eosinophilic Gastritis and/or Eosinophilic Duodenitis (Formerly Referred NCT04620811 | Allakos Inc. | Phase 3 |
| Completed | A Study to Assess AK002 in Eosinophilic Gastritis and/or Eosinophilic Duodenitis (Formerly Referred to as Eosi NCT04322604 | Allakos Inc. | Phase 3 |
| Completed | An Extension Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Duodenitis NCT03664960 | Allakos Inc. | Phase 2 |